Published in Anticancer Res on September 22, 1994
Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol (2014) 1.32
Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family. Clin Exp Immunol (1998) 0.79
Peers, schools, and adolescent cigarette smoking. J Adolesc Health (2001) 5.11
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS (1996) 2.41
Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst (1998) 2.32
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet (1992) 1.81
Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res (2000) 1.70
Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy. Clin Infect Dis (2000) 1.65
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology (2011) 1.65
Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage (1998) 1.64
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis (1999) 1.56
Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology (2002) 1.55
Passionate kissing and microlesions of the oral mucosa: possible role in AIDS transmission. JAMA (1989) 1.54
Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study. J Chemother (2007) 1.50
Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions. J Clin Microbiol (1997) 1.49
Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. Biochem Soc Trans (2004) 1.49
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011. BJOG (2013) 1.44
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43
Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J Chemother (2009) 1.38
Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res (2001) 1.36
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Mass vaccination against hepatitis B in infants in Italy. Lancet (1988) 1.33
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.32
The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem (1994) 1.32
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology (1997) 1.31
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. HIV Med (2009) 1.29
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol (1993) 1.29
Chemotherapy for invasive thymoma. A 13-year experience. Cancer (1991) 1.28
Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur J Immunol (1997) 1.22
Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol (1995) 1.22
Hepatitis B antigen inhibitor in human faeces and intestinal mucosa. Br Med J (1973) 1.19
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. Eur Respir J (2010) 1.17
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis (2007) 1.16
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect (2011) 1.15
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women. Br J Clin Pharmacol (2006) 1.15
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
Distribution of the intestinal factor of normal mice which inactivates murine virus hepatitis. Nature (1965) 1.14
Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol (1998) 1.13
Effect on the infectivity of various viruses by the intestinal factor of normal mice which inactivates murine hepatitis virus. Nature (1967) 1.12
Chemotherapy of invasive thymoma. J Clin Oncol (1990) 1.11
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (1997) 1.10
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol (1996) 1.09
p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation. Oncogene (2010) 1.09
Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer (1994) 1.08
Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.06
Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis. Eur Respir J (1997) 1.05
Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet (1985) 1.04
Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol (1999) 1.03
Presence of HBsAg in the bile of subjects with acute HBsAg viral hepatitis. Pathol Microbiol (Basel) (1975) 1.03
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. Clin Infect Dis (2010) 1.02
Genetics, metabolism and host specificity of Pneumocystis carinii. Med Mycol (1998) 1.01
Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis. Virchows Arch (1994) 1.01
Variable efficiency of three primer pairs for the diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction. Mol Cell Probes (1995) 1.01
Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis (1997) 1.00
Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res Hum Retroviruses (1995) 1.00
Letter: Hepatitis B not transmissible via faecal-oral route. Lancet (1975) 1.00
Two-dose hepatitis B immunisation regimen for infants. Lancet (1985) 1.00
[Hepatic injury and halogenated anesthetics: preliminary clinical experience]. Acta Biomed Ateneo Parmense (1985) 1.00
Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry (1995) 0.99
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. Oncogene (2011) 0.99
Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol (1993) 0.98
Letter: Fulminant viral hepatitis. Lancet (1975) 0.97
Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agents (2001) 0.96
Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis (2001) 0.96
Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol (1995) 0.96
Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett (1993) 0.95
Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis. Clin Exp Immunol (1979) 0.94
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med (2012) 0.93
The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect (1995) 0.93
The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS (1989) 0.93
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92
Role of the genetic study in the management of carotid body tumor in paraganglioma syndrome. Eur J Vasc Endovasc Surg (2008) 0.92
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell Immunol (1988) 0.91
Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect (2006) 0.91
Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Infection (2006) 0.91
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. J Interferon Cytokine Res (2001) 0.91
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol (1991) 0.90
Injury survey in competitive sub-elite rhythmic gymnasts: results from a prospective controlled study. J Sports Med Phys Fitness (2007) 0.90
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. AIDS Res Hum Retroviruses (1993) 0.89
Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis. Clin Exp Immunol (1980) 0.89
Diminished interferon gamma production may be the earliest indicator of infection with the human immunodeficiency virus. Viral Immunol (1989) 0.88
[A familial outbreak of adenovirus type 21 infection (follicular conjunctivitis)]. Riv Ist Sieroter Ital (1969) 0.88
Simple and rapid two-step polymerase chain reaction for diagnosis of Pneumocystis carinii infection. J Clin Microbiol (1993) 0.88
Bordetella bronchiseptica pneumonia in an AIDS patient: a new opportunistic infection. Infection (1996) 0.88
p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation. Oncogene (2011) 0.88
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol (1999) 0.88